Abstract:BackgroundDystrophin (DMD) gene mutations can affect muscular dystrophin isoform expression and result in progressive muscular dystrophy including Duchenne and Becker muscular dystrophies (DMD and BMD). To establish the correlation between phenotype and genotype and exemplify the current and future treatment for muscular dystrophy disorders, we investigated 20 patients suffering from a dystrophinopathy and summarized clinical manifestation and gene mutations of them. MethodsThe clinical manifestations, physical examination, laboratory work, and gene mutation results were collected in 20 patients with DMD or BMD diagnosed by clinical phenotype and genetic sequencing from July 2015 to December 2019. Multiplex ligation probe amplification (MLPA) and next-generation sequencing (NGS) were used to detect mutations in the DMD gene, and detected mutations were confirmed by Sanger sequencing. ResultsThe clinical manifestation of patients was characterized by progressive symmetrical muscle degeneration, limb weakness, and pseudohypertrophy along with the elevated concentration of creatine kinase, alanine aminotransferase, and aspartate aminotransferase. We found 11 dystrophin gene deletions (55%) and 4 duplication mutations (20%) among the affected patients. However, we also found point mutations including 1 nonsense (20%), 3 frameshifts (60%), and 1 splice sites (20%) mutations in the rest 5 patients. Among the 15 cases of exon deletion or duplication mutations, 7 were inherited from the mother, 3 were de-novo, while the other 5 were not tested. Besides, all 5 point-mutation cases were inherited from the mother, among which 4 point mutations were identified for the first time and linked to the disease phenotype. ConclusionsWe provided clinical portraits, genetic results, and the molecular effects of mutations in patients. Four novel point mutations were identified for the first time and associated with the development of DMD and BMD. Further, we expanded knowledge of the DMD variant spectrum and exemplified the emerging therapies in muscular dystrophy.

Clinical and genetic interpretation of uncertain DMD missense variants: evidence from mRNA and protein studies

Comprehensive Genetic Diagnosis of Patients with Duchenne/Becker Muscular Dystrophy (DMD/BMD) and Pathogenicity Analysis of Splice Site Variants in the DMD Gene

Functional Analysis of Variants in DMD Exon/intron 10 Predicted to Affect Splicing

Three novel splicing mutations at 5' terminal of DMD gene corresponding to different phenotypes

Clinical, Muscle Imaging, and Genetic Characteristics of Dystrophinopathies with Deep-Intronic DMD Variants.

Clinical and Laboratory Interpretation of Mitochondrial Mrna Variants

DMD Mutations in 576 Dystrophinopathy Families: A Step Forward in Genotype-Phenotype Correlations

Targeted Next-Generation Sequencing As a Comprehensive Test for Patients with and Female Carriers of DMD/BMD: a Multi-Population Diagnostic Study

Two Novel Deep Intronic Variants Cause Duchenne Muscular Dystrophy by Splice-Altering Mechanism

First Identification of Rare Exonic and Deep Intronic Splice-Altering Variants in Patients With Beta-Sarcoglycanopathy

Identification of Two Rare Mutations C.1318g>a and C.6438+2t>g in a Chinese DMD Family As Genetic Markers

Genetic Variation Analysis and Treatment Strategy of 20 Patients with Dystrophin Gene Mutations

Splicing Characteristics of Dystrophin Pseudoexons and Identification of a Novel Pathogenic Intronic Variant in the <i>DMD</i> Gene

RNA-seq analysis, targeted long-read sequencing and in silico prediction to unravel pathogenic intronic events and complicated splicing abnormalities in dystrophinopathy

A Novel Deep Intronic Variant Introduce Dystrophin Pseudoexon in Becker Muscular Dystrophy: A Case Report

Screening of Duchenne Muscular Dystrophy (DMD) Mutations and Investigating Its Mutational Mechanism in Chinese Patients.

Dmd Mutation Spectrum Analysis in 613 Chinese Patients with Dystrophinopathy

Splicing Characteristics of Dystrophin Pseudoexons and Identification of a Novel Pathogenic Intronic Variant in the DMD Gene

Identification of Two Novel Variants of the DMD Gene in Chinese Families with Duchenne Muscular Dystrophy

RNA Sequencing Facilitates the Identification of Genetic Causes of Duchenne Muscular Dystrophy and Proposes a Stepwise DMD Diagnostic Procedure

Cryptic Exon Activation Caused by a Novel Deep-Intronic Splice-Altering Variant in Becker Muscular Dystrophy.